Lataa...
Immune checkpoint inhibitors in malignancy
Immune checkpoints normally stop the body from mounting an immune response against healthy cells. Some cancers can acquire these checkpoints so that the tumour cells are not recognised by the immune system Inhibiting the checkpoints therefore enables the tumour cells to be recognised and allows an i...
Tallennettuna:
| Julkaisussa: | Aust Prescr |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
NPS MedicineWise
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6478962/ https://ncbi.nlm.nih.gov/pubmed/31048940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18773/austprescr.2019.012 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|